KnowGovRepresentation. Influence. Action.
BillS 4692 · 119

Homeopathic Drug Product Safety, Quality, and Transparency Act

Introduced
Jun 4, 2026
Cosponsors
1
Traction
0
Last Action
Jun 4, 2026

Bill Summary

Requires homeopathic drug products to meet certain safety, quality, and transparency standards. Funds and establishes procedures for ensuring these standards are met.

Sponsored By

Tommy Tuberville
Republican · Alabama · Senate

Bill Journey

  1. Jun 4, 2026
  3. Jun 4, 2026You Are Here

    The committee will review the bill, debate amendments, and vote on whether to advance it to the full chamber.

  4. TBD

    The full chamber debates the bill, may amend it, and votes on whether to pass it.

  5. TBD

    If passed by the first chamber, the other chamber considers, may amend, and votes on the bill.

  6. TBD

    If passed by both chambers, the bill goes to the President to sign into law or veto.

Why It Matters

This bill affects manufacturers and consumers of homeopathic drug products, requiring companies to adhere to stricter safety and quality guidelines, and giving consumers more information about the products they use. It also impacts the homeopathic industry as a whole, with potential changes to production and labeling practices.

Impact Areas

Sample
Addresses Supply
Targets an underlying shortage driving costs.
Supports Families
Aimed at easing pressure on working households.
Long-term Impact
Effects compound across multiple budget cycles.
Expands Access
Lowers barriers for first-time participants.

Support & Opposition

Sponsor & cosponsor support by party
1backer
  • Republican1
Cross-party cosponsors0 · 0%

Documents

1

Full text opens on congress.gov, the official source.

Bill Details

Bill TypeSenate Bill · Federal
Primary Topic—
CommitteeCommittee on Health
IntroducedJun 4, 2026
Last UpdatedJun 4, 2026
Latest ActionRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summary and impact analysis written by Judy (KnowGov's enrichment AI). Bill metadata, status, sponsor, and any floor votes from Prism. Sections marked “Sample” are placeholders not yet connected to live data.